Credit Suisse Group reaffirmed their buy rating on shares of Encompass Health (AMEX:EHC) in a research report released on Thursday, AnalystRatings.com reports.
A number of other brokerages have also weighed in on EHC. Mizuho decreased their target price on shares of Encompass Health from $90.00 to $87.00 and set a buy rating for the company in a research note on Friday, May 29th. Jefferies Financial Group cut their price target on Encompass Health from $90.00 to $86.00 and set a buy rating for the company in a report on Monday, July 27th. One analyst has rated the stock with a sell rating, one has issued a hold rating and twelve have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $87.20.
Encompass Health has a 1-year low of $40.86 and a 1-year high of $59.29.
Encompass Health (AMEX:EHC) last announced its earnings results on Monday, July 27th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.08). The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.05 billion. The company’s revenue was down 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.08 EPS.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of ∞. The ex-dividend date of this dividend is Wednesday, September 30th.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Read More: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.